Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2012 Jan 25;307(4):408-10.
doi: 10.1001/jama.2012.24.

Unwrapping the implications of BRCA1 and BRCA2 mutations in ovarian cancer

David M Hyman, David R Spriggs
Editorial

Unwrapping the implications of BRCA1 and BRCA2 mutations in ovarian cancer

David M Hyman et al. JAMA. .
No abstract available

PubMed Disclaimer

Comment on

  • Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.
    Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ, Karlan BY, Lambrechts D, Despierre E, Barrowdale D, McGuffog L, Healey S, Easton DF, Sinilnikova O, Benítez J, García MJ, Neuhausen S, Gail MH, Hartge P, Peock S, Frost D, Evans DG, Eeles R, Godwin AK, Daly MB, Kwong A, Ma ES, Lázaro C, Blanco I, Montagna M, D'Andrea E, Nicoletto MO, Johnatty SE, Kjær SK, Jensen A, Høgdall E, Goode EL, Fridley BL, Loud JT, Greene MH, Mai PL, Chetrit A, Lubin F, Hirsh-Yechezkel G, Glendon G, Andrulis IL, Toland AE, Senter L, Gore ME, Gourley C, Michie CO, Song H, Tyrer J, Whittemore AS, McGuire V, Sieh W, Kristoffersson U, Olsson H, Borg Å, Levine DA, Steele L, Beattie MS, Chan S, Nussbaum RL, Moysich KB, Gross J, Cass I, Walsh C, Li AJ, Leuchter R, Gordon O, Garcia-Closas M, Gayther SA, Chanock SJ, Antoniou AC, Pharoah PD; EMBRACE; kConFab Investigators; Cancer Genome Atlas Research Network. Bolton KL, et al. JAMA. 2012 Jan 25;307(4):382-90. doi: 10.1001/jama.2012.20. JAMA. 2012. PMID: 22274685 Free PMC article.

References

    1. Boyd J, Sonoda Y, Federici MG, et al. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA. 2000 May 3;283(17):2260–2265. - PubMed
    1. Chetrit A, Hirsh-Yechezkel G, Ben-David Y, Lubin F, Friedman E, Sadetzki S. Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer. J Clin Oncol. 2008 Jan 1;26(1):20–25. - PubMed
    1. Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474(7353):609–615. - PMC - PubMed
    1. Meijers-Heijboer EJ, Verhoog LC, Brekelmans CT, et al. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet. 2000 Jun 10;355(9220):2015–2020. - PubMed
    1. Kauff ND. Is It time to stratify for BRCA mutation status in therapeutic trials in ovarian cancer? Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Jan 1;26(1):9–10. - PubMed